KS79356, a novel kynureninase inhibitor, suppresses triple-negative breast cancer progression by attenuating the TNF-α/NFκB–CD44–Akt signaling axis
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.